Glycologix
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
100 Cummings Ctr Ste 438N, Beverly, Mass...Phone Number
(617) 480-2536Website
www.glycologix.comRevenue
<$5 MillionIndustry
About Glycologix
Glycologix Org Chart
Is Glycologix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Glycologix has recently received funding, and reach out quickly before it becomes old news!
Check out if Glycologix is spiking on competitors!
Earning: See what the market has to say on Glycologix recently announced quarterly report
Funding: Get notified immidiatlly once Glycologix has new funding data
Glycologix, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Glycologix launches new products
Congratulate Masked Content for being promoted to Masked Content at Glycologix
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Glycologix had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Glycologix
Find 3 more new buyers
Compare Similar Companies to Glycologix
Compare insights from companies similar to Glycologix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Glycologix is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Glycologix is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Glycologix.
Glycologix Tech Stack
A closer look at the technologies used by Glycologix
Glycologix News & Media
Glycologix Treats First Patient in Pilot Study of GLX-100 for Treatment of Interstitial Cystitis/Bladder Pain Syndrome
BEVERLY, Mass. & MELBOURNE, Australia--(BUSINESS WIRE)--Glycologix, Inc. (“Glycologix”), a clinical-stage company focused on developing biopolymers for the protection and repair of soft tissues, today announced the treatment of the first patient in a pilot clinical study evaluating GLX-100 as a novel treatment for Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS). The multi-center pilot trial is designed to assess the safety, tolerability and effectiveness of GLX-100 in participants with IC/
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Glycologix
Glycologix, Inc. is an innovative clinical-stage biotechnology company focused on developing locally delivered biopolymers for the protection and repair of soft tissues. Their technology mimics natural proteoglycans and addresses significant unmet medical needs, starting with their lead program, GLX-100, for interstitial cystitis/bladder pain syndr... Read More